Department of Defense (DoD) Health Program research opportunities are posted below. Grants with the shortest deadlines or that require pre-applications are posted first.

Contact the UAMS Office of Research for information on application tips, current UAMS DoD funding  grantees, and UAMS DoD reviewers. Contact the Office of Research and Sponsored Programs for submission assistance, eligibility questions, or other grant funding questions.


Department of Defense Psychological Health and Traumatic Brain Injury Research Program (PHTBIRP)
The Federal Interagency Traumatic Brain Injury Research (FITBIR) data identifies actionable insights for the diagnosis, management, and treatment of traumatic brain injury.

DEADLINE: August 7, 2019 (Letter of Intent); September 5, 2019 (full application)
Federal Interagency Traumatic Brain Injury Research Analysis Award
Proposed projects must address FITBIR topics and animal research or
active enrollment of human subjects is not allowed.

DEADLINE: September 19, 2019 (Letter of Intent); October 3, 2019 (Full application)
Prevention Research to Reduce Sexual Assault and/or Understand Adjustment Disorders Investigator-Initiated Focused Research Award (PSAAD-IIFRA)
The PSAAD IIFRA supports research focused on (1) development/adaptation efforts to reduce the occurrence of sexual assault and/or harassment, (2) understanding the diagnosis, assessment, and screening of adjustment disorders resulting from sexual assault and/or stressors that precipitate adjustment disorders. Human subject research is permitted, but award may not be used to conduct clinical trials. Preclinical animal research is not permitted. Max funding $750K (direct/indirect costs) for 3 yrs.

Clinical Research Award (CTRR-CRA)
DEADLINE: September 10, 2019 (Preproposal due); December 2, 2019 (Full proposal by invitation)
Supports applied/translational research to advance knowledge and products for rehabilitation and function restoration after traumatic brain injury. Max funding $2 million (direct/indirect costs) for 3 years.

CTRR – Clinical Trial Award (CTRR-CTA)
DEADLINE: September 10, 2019 (Preproposal due); December 2, 2019 (Full proposal by invitation)
Supports clinical trials to validate existing complex mild TBI (mTBI) rehabilitation interventions and practice patterns; Clinical trials must measure intervention effects and effectiveness of standard-of-care practices in remediating post mTBI sequelae across the spectrum of  functional vulnerabilities. Max funding $4 million (direct/indirect costs) for 3 years.

Synopsis

___________________
Department of Defense Melanoma Research Program
DEADLINE: July 26, 2019 (Pre-proposal); October 23, 2019 (Full application)
The DoD Melanoma Research Program (MRP) supports innovative, high-impact melanoma research (e.g., precursor lesions, melanomagenesis, host factors, tumor microenvironment/evolution; therapeutic prevention: residual disease; rare melanomas).
Idea Award – $300,000 (direct/indirect costs) for 3 yrs; Team Science Awards (2-3 investigators must partner in a multidisciplinary research study), $700,000 (direct/indirect) costs for 3 yrs; and Translational Research Award – studies with existing biobanks, biorepositories, ongoing/completed clinical trials on translational melanomas. DoD/VA participation encouraged, preliminary data required, and new clinical trials not allowed. Max $600,000 (direct/indirect costs) for 3 yrs.
Concept Award – October 2, 2019 (Letter of Intent); October 23, 2019 (Full application)
For the exploration of highly innovative, untested, melanoma concepts.  Preliminary data strongly discouraged and clinical trials are not allowed. $75,000 in direct costs (indirects negotiated) for 1 yr.

Synopsis
___________________
Department of Defense Gulf War Illness Research Program
DEADLINE: July 12, 2019 (Pre-application required); October 3, 2019 (Full application by invitation)  The GWIRP supports research in Gulf War Illness pathobiology, diagnosis, and treatment.

Idea Award – Max funding $150,000 for direct/indirect costs. Max funding of $170,000 (direct/indirect costs) Biorepository Contribution Option; Max period 2 yrs.
Clinical Evaluation Award – Max funding $1,000,000 (direct/indirect costs); Max funding $1,020,000 (direct/indirect costs) with Biorepository Contribution. Max funding $1,200,000 (direct/indirect costs) with Clinical Consortium Collaboration for 3 yrs.
Therapeutic/Biomarker Trial Award – Max funding $5,000,000 (direct/indirect costs); Max funding $5,020,000 (direct/indirect costs) for Biorepository Contribution; Max funding $5,500,000 (direct/indirect costs) Clinical Consortium Collaboration for 4 yrs.
Patient-Provider and Health Communications Award – Max funding $700,000 (direct/indirect costs) for 3 yrs.
New Investigator Award – 3 eligibility categories: Transitioning Postdoc; Postdoc (3 yrs of postdoc  training); Early-Career Investigator (5 yrs since last training position); New GWI researcher (Established PI with less than $300,000 in federally funded, non-mentored GWI research). GWI researchers collaborations strongly encouraged. Preliminary data not required; Clinical trials not allowed. Max funding $500,000(direct/indirect costs); Max funding $520,000 (direct/indirect costs) with Biorepository Contribution.
Research Advancement Award – Max funding $700,000 for direct/indirect costs. Max funding $720,000 (direct/indirect costs) Biorepository Contribution for 3 yrs.

Synopsis

___________________
DEPSCoR: Defense Established Programs to Stimulate Competitive Research
U.S. Army YIP is a rolling acceptance program with no fixed suspense date.
DEADLINE: Air Force YIP – June 3, 2019
DEADLINE: Navy YIP – August 16, 2019

The Army Research Office (ARO), Air Force Office of Scientific Research (AFOSR), and Office of Naval Research (ONR) build facility capacity/increase research infrastructure. DEPSCoR augments existing programs in DEPSCoR-eligible states/territories. Specifically: Young Investigator Program (YIP) and the Defense University Research Instrumentation Program (DURIP).

(1) Helps higher education develop science and engineering (S&E) research relevant to DoD mission; (2) Increase university researchers doing S&E research in eligible states/territories; and (3) Increase long-term growth in eligible states/territories that receive federal S&E funding.

___________________
Department of Defense Reconstructive Transplant Research (RTRP)
The RTR seeks to advance the science and execution of complex hand, face and other vascularized composite allotransplantation (VCA) procedures.

DEADLINE: July 17, 2019 (Pre-applicaton); October 16, 2019 (Full application by invitation)
Idea Discovery Award – Max funding $500,000 for direct/indirect costs for 2 yrs.
Investigator-Initiated Research Award – Max funding $1 million (direct/indirect costs) for 3 yrs.
Multi-institutional Partnerships –  (2-4 PIs required), Max funding $1.5 million (direct/indirect costs) for 3 yrs.

Synopsis 

___________________
Department of Defense Vision Research Program 
DEADLINE: August 6, 2019 (Pre-proposal); December 6, 2019 (Full application – by invitation)
The VRP supports military vision research in: Eye injury or visual dysfunction; Blast, blunt, thermal, or chemical trauma; Trauma caused by directed energy weapons; Diagnosis/treatment of eye injuries in austere environment.

Investigator-Initiated Research Award – Level I Max funding $260,000 (direct/indirect costs) for 2 yrs. Level II Max funding $500,000 (direct/indirect costs) for 3 years.

Translational Research Award – Max funding of $750,000 (direct/indirect costs) for 3 yrs.

Focused Translational Team Science Award – Lead PI is required to have minimum 20% effort. Applications must include 3-5 five distinct research projects. Max funding $5,000,000 (direct/indirect costs) for 4 yrs.

Synopsis

___________________
Restoring Warfighters with Neuromusculoskeletal Injuries Research Award (RESTORE)
RESTORE focuses on optimal management, treatment, and restoration after Service-related Neuromusculoskeletal injury (e.g., acute combat/non-combat injury, repetitive overuse injury, limb loss, and limb trauma). Collaboration among academia, industry, DoD, and VA is encouraged.

DEADLINE: September 3, 2019 (Pre-Application); December 16, 2019 (Full proposal)
RESTORE offers three Research Levels:
Research Level 1 – New ideas that represent innovative approaches. Max funding $500,000 (direct/indirect costs) for 3 yrs.
Research Level 2 – Advancing laboratory discovery, population-based studies, or
clinical knowledge; May include preclinical studies in animal models and human subjects. Max funding $1,500,000 (direct/indirect costs) for 4 yrs.
Research Level 3 – Clinical trials with significant impact on neuromusculoskeletal injuries. Max funding $3,000,000 (direct/indirect costs) for 4 yrs.

Synopsis

___________________

Department of Defense Kidney Cancer Research Program (KCRP)
The KCRP Concept Award supports highly innovative, untested, novel concepts in kidney cancer.
DEADLINE: September 17, 2019 (Letter of Intent ); October 1, 2019 (Full application)
Concept Award – Maximum funding of $75,000 for direct/indirect costs for 1 yr. Clinical trials not allowed. Preliminary data not allowed.
Idea Development Award – Preliminary data required. Clinical trials not allowed. Maximum funding of $400,000 in direct/indirect costs for 2 yrs.
Translational Research Partnership Award -Maximum funding of $600,000 for direct/indirect costs for 3 yrs. Supports partnerships between clinicians/scientists that accelerate kidney cancer clinical applications; Supports translational correlative studies; Preliminary data required; Clinical trials not allowed.

Synopsis

_____________________
Department of Defense Clinical and Rehabilitative Medicine Research Program
The (JPC-8/CRMRP) supports the development of regenerative medicine solutions and technical capabilities that repair, reconstruct, or regenerate tissue lost or damage due to traumatic injury through collaborative partnerships and synergistic projects. All projects will be required to address peripheral nerve and/or skeletal muscle regeneration.

DEADLINE: August 7, 2019 (Pre-application ); November 20, 2019 (Full application); Max funding of $10 million for direct/indirect costs for 5 yrs.

Synopsis 

______________________
Department of Defense Chronic Pain Management Research Program
The Department of Defense Chronic Pain Management Research Program (CPMRP) supports research of exceptional scientific merit with the potential to make a significant impact on improving the health and quality of life of Service members, Veterans, and all Americans living with chronic pain.
DEADLINE: September 13, 2019 (Pre-proposal due); December 6, 2019 (Full application)

CPMRP required focus areas include:
Investigator-Initiated Research Award -“Chronification” of Pain (i.e., the acute-to-chronic pain transition); Clinical trials are not allowed, Maximum $900,000 for direct/indirect costs for 4 yrs.

Translational Research Award – Implementation Science (evidence-based, efficacious interventions to manage chronic pain); Must include preliminary and/or published data; May include studies using prospective human subject enrollment or retrospective data analysis; limited clinical studies are allowed; Animal studies not allowed. Maximum funding of $1,400,000 for direct/indirect costs for 4 yrs.

_____________________________________________________

Check archived DOD funding opportunities for upcoming cycles.

Department of Defense Prostate Cancer Research Program (PCRP)
The PCRP develops treatments to improve prostate cancer outcomes, reduce prostate cancer in African Americans, Veterans, and high-risk populations, define prostate cancer biology, and improve survivors quality of life.

DEADLINE: June 6, 2019 (Pre-proposal); September 19, 2019 (Full application)
Idea Award – Max funding $750,000 for direct/indirect costs. New Investigators – Max funding $600,000 (direct/indirect costs) for 3 yrs.

DEADLINE: June 6, 2019 (Pre-proposal); June 27, 2019 (Full application)
Early Investigator Award – Max funding $200,000 (direct/indirect costs) for 2 years.
Physician Research Award – Max funding $750,000 (direct/indirect costs) for 4 years.

DEADLINE: June 27, 2019 (Pre-proposal); July 18, 2019 (Full application)
Clinical Trial Award – Early-phase clinical trials (e.g., Phase 0, Phase I, pilot Phase II) to
test interventions. Max funding $2,000,000 (direct/indirect costs) for 4 yrs.
Health Disparity Research Award – Max funding $750,000 (direct/indirect costs); New Investigators – Max funding $600,000 (direct/indirect costs) for 3 yrs.
Synergistic Population and Data Science Award – Max funding $1,500,000 (direct/indirect costs) for 4 yrs.
Translational Science Award – Max funding $750,000 (direct/indirect costs) for 3 yrs.

Synopsis

__________________
Department of Defense Epilepsy Research Program (ERP) and Idea Development Award
DEADLINE: June 26, 2019 (Letter of Intent); July 17, 2019 (Full application)
The ERP FY19 Focus Areas are in Basic Research (e.g.,  biomarkers, therapeutic targets, early detection); Epidemiology (e.g., risk factors); and Longitudinal Studies (e.g., seizure frequency/severity, anatomy/pathology, injury type, depression, sleep disorders). Max funding of $300,000 – Level I for direct/indirect costs for 3 yrs. and $500,000 – Level II for 3 yrs.

Synopsis

___________________
Department of Defense Peer Reviewed Breast Cancer Research Program (BCRP)
DEADLINE: August 22, 2019 (Letter of Intent); September 5, 2019 (Full application)
The BCRP FY19 Focus Areas are Level I – Early stage, high risk/high-reward research; Level II – Preclinical research supported by substantial preliminary/published data with clinical translation partnering; and Level II – Population science and prevention studies. Level I – Max funding of $450,000 ($750,000 with partnering) for direct/indirect costs for 3 yrs. Level II – Max funding of $1 million ($1.5 million with partnering) for direct/indirect costs for 3 yrs. Level II Population science and prevention studies – Max funding of $1.5 million ($2 million with partnering) for direct/indirect costs for 4 yrs.

Synopsis

___________________
Department of Defense Lung Cancer Research Program (LCRP)
The LCRP seeks to identify innovative strategies for the early detection of lung cancer; understand the molecular mechanisms, prevention, treatment, and recurrence of lung cancer.

DEADLINE: July 24, 2019 (Letter of Intent ); August 7, 2019 (Full application )
Concept Award – Max funding $100,000 for direct/indirect costs. for 1 yr. Clinical trials not allowed. Relevance to Military Health strongly encouraged.

DEADLINE: August 1, 2019 (Pre-proposal); August 21, 2019 (Full application deadline)
Career Development Award – Max funding $250,000 (direct/indirect costs) for 2 yrs.

Synopsis
___________________

Department of Defense Peer Reviewed Orthopaedic Research Program (PRORP)
DEADLINE: June 26, 2019 (Pre-proposal); September 18, 2019 (Full application – by invitation)
PRORP’s Applied Research Award seeks research in the following FY19 focus areas:  1) Compartment Syndrome Models, Limb Stabilization and Protection; 2) Rapid Limb Stabilization/Wound Protectants; 3) Retention on Duty Strategies; 4) Skin-implant Interface; 5) Translation of Early Findings to Clinical Trials/practice; and 6) Tissue Regeneration Therapeutics. Max funding of $750,000 for total costs (direct/indirect costs) for 3 yrs.
Clinical Trial Award  Same focus areas/deadline. Max funding of $2.5 million – Level I (direct/indirect costs) for 4 yrs. and max funding of $3M (direct/indirect) for 4 yrs.
Clinical Translational Research Award  Same focus areas/deadline. Max funding of $2M  (direct/indirect costs) for 4 yrs.

Synopsis

___________________
Department of Defense Peer Reviewed Alzheimer’s Research Program
DEADLINE: June 26, 2019 (Letter of Intent); July 17, 2019 (Full application)
The DoD Peer Reviewed Alzheimer’s Research Program (PRARP) supports research on long-term consequences of traumatic brain injury for Alzheimer’s disease/dementias via 3 award mechanisms – Convergence Science Research Award, Innovation in Care and Support Award, and Research Partnership Award.  Topical areas include: Paucity of Research Resources; Paucity of Clinical Studies; Diagnostics/Prognostics; Epidemiology; Quality of Life; and Family/Care Support. Max funding of Level I – $225,000 (direct/indirect) costs for 3 yrs.  Level II – Max funding of $500,000 (direct/indirect costs) for 3 yrs.

Synopsis